Algernon Pharmaceuticals' NP-120 (Ifenprodil) Outperforms Merck's Phase 3 Drug MK-7264 (Gefapixant) in an Acute Cough Study by 110%
Stock Information for Algernon Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.